Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ALS
Pharma
Amylyx's ALS drug finally scores a positive vote from FDA panel
Yesterday was the long-awaited second meeting of the FDA’s expert panel to weigh in on Amylyx’s ALS drug, and this time, AMX0035 came away with a nod.
Zoey Becker
Sep 8, 2022 8:16am
Amylyx's ALS drug faces tough FDA scrutiny—again
Sep 6, 2022 4:38pm
ALS Association pushes for FDA approval of pending Amylyx drug
Sep 15, 2021 11:11am
New Alzheimer's drug gives price reformers their poster child
Jun 10, 2021 10:29am
JPM: Alexion to take next-gen Ultomiris into tough ALS study
Jan 14, 2020 5:00pm
Radicava stalls in EU as skeptical regulators demand new ALS trial
May 31, 2019 12:19pm